Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


PHARMAC targets high cost of diabetes test strips

PHARMAC targets high cost of diabetes test strips

The high cost of diabetes monitoring is being targeted by PHARMAC with a decision to reference price blood glucose test strips.

PHARMAC has reached an agreement with Bayer Diagnostics to continue fully funding its brand of test strips (Ascensia Glucodisc) in return for a 3 percent price reduction, and all other brands of test strips will be reference priced to this level. Bayer's brand was previously called Glucometer Esprit but the name has been changed to Ascensia Glucodisc.

Testing strips are used by people with diabetes to monitor their blood glucose levels, and currently account for more than $18 million per year of the pharmaceutical budget.

The agreement with Bayer includes a price reduction, but despite this reduction PHARMAC Chief Executive Wayne McNee says New Zealand will still be paying 15 to 18 percent more for testing strips than Australia.

“Reference pricing will produce a saving of $2.5 million over five years, and this is necessary to allow District Health Boards to meet their budgetary targets and to allow PHARMAC the possibility to reinvest in more medicines,” Wayne McNee says.

“However we remain concerned at the level of expenditure in this area, which is caused by both comparatively high prices and possible overuse of the test strips in type 2 diabetes.”

PHARMAC will undertake a review of its spending in this area later this year.

Following the implementation of reference pricing people with diabetes will have a number of options to enable them to choose their testing strips.

continue to use their current brand of test strips and pay the small manufacturer’s surcharge (about $1.67 for a pack of 50) when they have a prescription dispensed at a pharmacy have the prescription filled through a Diabetes NZ mail order service and not pay the manufacturer’s surcharge. Details of this service are available from Diabetes New Zealand (freephone 0800 DIABETES) change to the fully funded test strips and purchase a new meter.

The decision for testing strips takes effect from 1 March 2003.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>



Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news